Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Candida auris, a multidrug-resistant yeast that causes invasive infections, was first described in 2009 in Japan and has since been reported from several countries. METHODS: To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012-2015 and the type specimen from Japan. Patient information was available for 41 of the isolates. We conducted antifungal susceptibility testing and whole-genome sequencing (WGS). RESULTS: Available clinical information revealed that 41% of patients had diabetes mellitus, 51% had undergone recent surgery, 73% had a central venous catheter, and 41% were receiving systemic antifungal therapy when C. auris was isolated. The median time from admission to infection was 19 days (interquartile range, 9-36 days), 61% of patients had bloodstream infection, and 59% died. Using stringent break points, 93% of isolates were resistant to fluconazole, 35% to amphotericin B, and 7% to echinocandins; 41% were resistant to 2 antifungal classes and 4% were resistant to 3 classes. WGS demonstrated that isolates were grouped into unique clades by geographic region. Clades were separated by thousands of single-nucleotide polymorphisms, but within each clade isolates were clonal. Different mutations in ERG11 were associated with azole resistance in each geographic clade. CONCLUSIONS: C. auris is an emerging healthcare-associated pathogen associated with high mortality. Treatment options are limited, due to antifungal resistance. WGS analysis suggests nearly simultaneous, and recent, independent emergence of different clonal populations on 3 continents. Risk factors and transmission mechanisms need to be elucidated to guide control measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“C. auris, a novel Candida species first identified in 2009, has emerged since 2013 as a cause of nosocomial outbreaks in multiple countries across 5 continents.”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to all three classes of antifungals is reported most commonly in India in South Asia (3%), whereas this is much less common in other regions of the world.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Invasive C. auris infections are associated with high mortality rates, with 60% of hospitalizations due to C. auris infections resulting in death (8).”
From Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three such mutations, encoding the amino acid substitutions VF125AL (commonly referred to as F126L), Y132F, and K143R, are frequently reported among fluconazole-resistant clinical isolates, and associations between these mutations and specific genetic clades of C. auris have been observed (2).”
From Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, up to 96% of C. auris may exhibit resistance to fluconazole, an exceptionally high value compared to 0.5–2% for C. albicans, 4–9% for C. tropicalis, 2–6% for C. parapsilosis, and 11–13% for C. glabrata [16,40,41].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [16]
Experimental — accuracy not yet measured
29 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst197 · Cited by 47,205
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · cited 1×
“SNPs were identified using 2 independent pipelines, as described elsewhere (see also the legend to Supplemental Figure 1) [15, 19].”
MethodEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“auris because we did not have a comparison group of patients with other Candida infections from the same institutions [31].”
BackgroundResultNonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data
Chin, C.-S., Alexander, D. H., Marks, P., Klammer, A. A., Drake, J., Heiner, C., Clum, A., Copeland, A., Huddleston, J., Eichler, E. E., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2474 · Cited by 4,029 · cited 1×
“The reference genome was generated by de novo assembly of PacBio reads from isolate B8441, as described elsewhere [18], and used as a reference for single-nucleotide polymorphism (SNP) calling.”
MethodSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · cited 8×
“To understand the global emergence and epidemiology of C. auris, we obtained isolates from 54 patients with C. auris infection from Pakistan, India, South Africa, and Venezuela during 2012–2015 and the type specimen from Japan.”
BackgroundInfluentialEvolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 1×
“5 Mb, similar to that of other Candida species [25].”
BackgroundSelf-citationKathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532 · cited 1×
“It phenotypically resembles Candida haemulonii and requires use of molecular methods for identification [9, 10].”
MethodSelf-citationFirst Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H.-C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 523 · cited 2×
“auris [3], establishing that this new species was capable of causing invasive infections.”
BackgroundPerea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Incidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454 · cited 1×
“auris may become widely established within certain regions, as evidenced by the fact that it now accounts for nearly 5% of candidemia in Indian intensive care units [5].”
Background
Cited by
Items 901–1,000 of 1,007
Genetic Diversity of Human Fungal Pathogens
Freese, J. M., & Beyhan, S. (2023) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00188-4 · Cited by 13
Beredaki, M.-I., Sanidopoulos, I., Pournaras, S., & Meletiadis, J. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad583 · Cited by 13
“While resistance to antifungals is rather limited in other Candida spp, resistance in C. auris is more common [1, 2].”
BackgroundLiposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis
Huang, W., EBERLE, K. E., Rosario-Colon, J., Lovell, J. F., & Xin, H. (2024) · mSphere · doi:10.1128/msphere.00189-24 · Cited by 12
Todd, B. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000515233.51795.b3 · Cited by 15
“In a multicenter, international analysis, more than 40% of isolates were resistant to drugs in two of the major antifungal classes, and two isolates were resistant to all three.(4) Difficulties with identification.”
BackgroundA synthetic construct for genetic engineering of the emerging pathogenic yeast Candida auris
Defosse, T. A., Govic, Y. L., Vandeputte, P., Courdavault, V., Clastre, M., Bouchara, J., Chowdhary, A., Giglioli‐Guivarc’h, N., & Papon, N. (2017) · Plasmid · doi:10.1016/j.plasmid.2017.11.001 · Cited by 12
Self-citationSana, F., Hussain, W., Zaman, G., Satti, L., Khurshid, U., & Khadim, M. T. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.06.011 · Cited by 12
Heindel, J., Zweigner, J., Fuchs, F., & Hamprecht, A. G. (2022) · Mycoses · doi:10.1111/myc.13533 · Cited by 13
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia
Bels, D. D., Maillart, E., Bambeke, F. V., Redant, S., & Honoré, P. M. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2142207 · Cited by 12
Wang, T. Z., White, K. N., Scarr, J. V., Simon, M. S., & Calfee, D. P. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.01.021 · Cited by 13
“auris isolates, suggesting the prior scarcity and recent emergence of this species.(4)”
BackgroundInfluentialSpecial Issue: Candida and Candidiasis
Nett, J. E. (2018) · Journal of Fungi · doi:10.3390/jof4030074 · Cited by 12
Successful treatment of a Candida auris intra-articular infection
Roberts, S. C., Zembower, T., Bolon, M. K., Kadakia, A. R., Gilley, J. H., Ko, J. H., Clark, J., Ward-Fore, S., & Taiwo, B. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1625287 · Cited by 12
Fast and Accurate Identification of Candida auris by High Resolution Mass Spectrometry
Jamalian, A., Freeke, J., Chowdhary, A., de Hoog, S., Stielow, J. B., & Meis, J. F. G. M. (2023) · Journal of Fungi · doi:10.3390/jof9020267 · Cited by 12
“auris isolates has shown that at least four and possibly five clades have emerged independently and simultaneously during the last 20 years [20,21].”
BackgroundSelf-citationTheiaEuk: a species-agnostic bioinformatics workflow for fungal genomic characterization
Ambrosio, F. J., Scribner, M. R., Wright, S. M., Otieno, J. R., Doughty, E. L., Gorzalski, A. J., Siao, D. D., Killian, S., Hua, C. N., Schneider, E., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1198213 · Cited by 14
“auris strains (93%) are resistant to fluconazole, and another 35% are resistant to AmpB (13).”
BackgroundInfluentialBentz, M. L., Le, N., Min, B., Nunnally, N. S., Sullivan, V., Tran, M., Lockhart, S. R., Litvintseva, A. P., Berkow, E. L., & Sexton, D. J. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03564-23 · Cited by 11
Self-citationEffect of Conformational Variability on the Drug Resistance of Candida auris ERG11p and FKS1
Izumi, H., Nafié, L. A., & Dukor, R. K. (2024) · ACS Omega · doi:10.1021/acsomega.3c08134 · Cited by 11
Patwardhan, S. A., Prayag, P. S., Soman, R. N., Purandare, B. D., Ramya, S., Dawra, R., Joshi, R., & Prayag, A. (2024) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2024.100618 · Cited by 12
Bayona, J. V. M., Cancino‐Muñoz, I., García, C. S., Tormo, N., Serrano, M. D. R. G., Ferrer‐Gómez, C., García, M. M. M., Gónzález‐Candelas, F., & Gimeno-Cardona, C. (2024) · Mycoses · doi:10.1111/myc.13776 · Cited by 11
Xiao, W., Zhou, H., Huang, J., Xin, C., Zhang, J., Wen, H., & Song, Z. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.02406-24 · Cited by 11
Diagnostic Challenges in Fungal Coinfections Associated With Global COVID‐19
Shahin-jafari, A., Nejad, A. S. M., Faraji, H., Abdel-Moneim, A. S., Asgari, S., Karami, H., Kamali, A., Vakilabad, A. A. K., Habibi, A., & Faramarzpour, M. (2025) · Scientifica · doi:10.1155/sci5/6840605 · Cited by 12
“Traditional phenotypic techniques have led to misidentifcation of C. auris , commonly mistaking it for C. sake , C. duobushaemulonii , Rhodotorula glutinis , C. haemulonii , or other Candida species [146].”
Octenidine effectively reduces Candida auris colonisation on human skin
Cerbu, D., Seiser, S., Phan-Canh, T., Moser, D., Freystätter, C., Matiasek, J., Kuchler, K., & Elbe‐Bürger, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-11914-x · Cited by 11
Candida auris Invasive Infection after Kidney Transplantation
Reque, J., Arlandis, R., Panizo, N., Pascual, M. J., & Alba, A. P. (2022) · Case Reports in Nephrology · doi:10.1155/2022/6007607 · Cited by 12
“Reduced susceptibility to triazole antifungals has been demonstrated in different regions, and there is also variable susceptibility of isolates to amphotericin B [7].”
BackgroundBowler, I. C. J. W., & Scarborough, M. (2020) · doi:10.1093/med/9780198746690.003.0071 · Cited by 11
Gaitán, A. C. R., Sigona-Giangreco, I. A., Pérez-Royo, J. M., García-Bustos, V., García-Hita, M., Valentín, E., Almaraz, S. G., de Groot, P. W. J., & Pemán, J. (2023) · Diagnostics · doi:10.3390/diagnostics13020231 · Cited by 14
“especially in developing countries [26,27].”
de la Fuente, I., Guridi, A., Jauregizar, N., Eraso, E., Quindós, G., & Sevillano, E. (2023) · Journal of Fungi · doi:10.3390/jof9060648 · Cited by 11
“In this way, although anidulafungin and amphotericin B have lower rates of resistance than fluconazole or other azoles, their combination with another product in order to achieve synergies would allow for a reduction in the dose and side effects [7].”
BackgroundMassic, L., Gorzalski, A. J., Siao, D. D., Dykema, P., Hua, C. N., Schneider, E., Hooser, S. V., Pandori, M., & Hess, D. C. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00434-6 · Cited by 12
Şengel, B. E., Ekren, B. Y., Sayın, E., Tigen, E. T., Seydaliyeva, A., Çerikçioğlu, N., Cinel, İ., Korten, V., Sezerman, O. U., & Odabaşı, Z. (2023) · Mycopathologia · doi:10.1007/s11046-023-00782-6 · Cited by 13
Ramírez, J. D., Wang, C. Y., Bolton, D., Liggayu, B., Schaefer, S. H., Patel, G., Javaid, W., Cordon‐Cardo, C., Firpo‐Betancourt, A., Sordillo, E. M., et al. (2023) · Journal of Fungi · doi:10.3390/jof9080849 · Cited by 12
Azami, H., Watanabe, Y., Sakai, K., Nakahara, H., Kojima, H., Tokiwa, T., Nonaka, K., Noguchi, Y., Nagano, Y., Hirose, T., et al. (2024) · The Journal of Antibiotics · doi:10.1038/s41429-023-00696-x · Cited by 11
“C. auris is an invasive fungal pathogen recognized worldwide as a serious health threat due to its extensive innate and acquired antifungal drug resistance [2].”
Finding Candida auris in public metagenomic repositories
Mario-Vasquez, J. E., Bagal, U. R., Lowe, E. K., Morgulis, A. O., Phan, J., Sexton, D. J., Shiryev, S. A., Slatkevičius, R., Welsh, R. M., Litvintseva, A. P., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291406 · Cited by 12
Self-citationA multicentric outbreak of Candida auris in Mexico: 2020 to 2023
la Garza, P. R.-D., Cruz, C., Bejarano, J. I. C., López-Romo, A. E., Delgado, J. V., Ramos, B. A., Neira, M. N. M., Rodríguez, D. S., Rodríguez, H. M. S., & Selvera, O. A. R. (2024) · American Journal of Infection Control · doi:10.1016/j.ajic.2024.07.012 · Cited by 11
A Bright Future for Fluorescence Imaging of Fungi in Living Hosts
Chapuis, A. F., Ballou, E. R., & MacCallum, D. M. (2019) · Journal of Fungi · doi:10.3390/jof5020029 · Cited by 12
“resistant to most of the currently available antifungals, are a growing health threat [17].”
BackgroundHigh-Resolution Genome-Wide Occupancy in Candida spp. Using ChEC-seq
Tebbji, F., Khemiri, I., & Sellam, A. (2020) · mSphere · doi:10.1128/msphere.00646-20 · Cited by 13
“auris, the clinical B8441 strain (52) was used for SAT1-MNase tagging.”
MethodProduction of Effective Phyto-antimicrobials via Metabolic Engineering Strategies
Sharma, A., Mistry, V., Kumar, V., & Tiwari, P. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220310104645 · Cited by 11
Alanís‐Ríos, S. A., González, G. M., Andrade, Á., Becerril-García, M. A., Bonifáz, A., Robledo-Leal, E., Montoya, A. M., & Treviño‐Rangel, R. D. J. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00817-y · Cited by 13
“Candidemia is the most common fungal infection, especially in low-immunity patients in the ICU; it is associated with a poor outcome and overall mortality approaching 68% [6].”
BackgroundInfluentialGonzález-Durán, E., Contreras-Pérez, C. U., Cáceres, D. H., Claudia, R.-R., Piñón-Ortega, J. D. J., Téllez-Saucedo, M. D., Marín-Suro, E. S., Wong-Arámbula, C. E., Moreno-Escobar, E. A., Ramírez–González, J. E., et al. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03159-3 · Cited by 14
Self-citationA Case for Antifungal Stewardship
Miller, R. A. (2018) · Current Fungal Infection Reports · doi:10.1007/s12281-018-0307-z · Cited by 12
Collins, J. M., Wallender, E. K., & Woodworth, M. H. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz529 · Cited by 11
Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades
Papp, Z. L., Borman, A. M., Forgács, L., Kovács, R., Tóth, Z., Chun-Ju, C., Kardos, G., Juhász, B., Szilvássy, J., & Majoros, L. (2021) · Pathogens · doi:10.3390/pathogens10080990 · Cited by 12
“auris infections, including meningitis, endophthalmitis, and urinary tract infections, cannot be reliably predicted using MIC results, which may explain the high mortality with AMB treatment [3,4].”
BackgroundResultde Oliveira, H. C., Castelli, R. F., Alves, L. R., Nosanchuk, J. D., Salama, E. A., Seleem, M. N., & Rodrigues, M. L. (2022) · Medical Mycology · doi:10.1093/mmy/myac033 · Cited by 12
Infection Control Measures against Candidaauris in Healthcare Facilities
Alfouzan, W. A., Dhar, R., Alabbad, J., & Rabaan, A. A. (2022) · Processes · doi:10.3390/pr10081625 · Cited by 10
Singh, R., Shukla, J., Ali, M. S., & Dubey, A. K. (2024) · Journal of Applied Microbiology · doi:10.1093/jambio/lxae139 · Cited by 11
Developing the trehalose biosynthesis pathway as an antifungal drug target
Washington, E. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00095-2 · Cited by 13
Liu, X., Guo, S., Wang, J., Zhang, L., Lin, Y., Liu, Y., Ouyang, J., Shi, D., Xu, S., Fang, W., et al. (2025) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2025.08.040 · Cited by 12
Differential susceptibility of Candida (Candidozyma) auris clades to surface disinfectants
Lang, A., Gabriel, H., Meister, T. L., Meis, J. F. G. M., Steinmann, E., Brill, F. H. H., & Steinmann, J. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.10.003 · Cited by 10
Self-citationElbehiry, A., Marzouk, E., Edrees, H. M., Abdelsalam, M. H., Aljizani, F., Alqarni, S., Khateeb, E., Alzaben, F. A., Ibrahem, M. D., Mousa, A., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15232944 · Cited by 14
“Early global genomics revealed nearly simultaneous emergence of Candida auris on three continents with distinct clades by WGS, establishing the need for genomic epidemiology alongside routine antimicrobial susceptibility testing [127,128].”
Durante, A. J., Maloney, M., Leung, V., Razeq, J. H., & Banach, D. B. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2018.133 · Cited by 10
Candida auris and other phylogenetically related species – a mini-review of the literature
Ciurea, C. N., Mare, A. D., Kosovski, I.-B., Toma, F., Vintilă, C., & Man, A. (2021) · GERMS · doi:10.18683/germs.2021.1281 · Cited by 13
“Independent different clonal populations (clades separated by thousands of singlenucleotide polymorphisms) have been identified on 3 continents.(9) Although it is commonly accepted that there are four major clades: the South Asian (I), Asian (II), African (III), and”
BackgroundPedraza‐Sánchez, S., Cruz-González, A., Palmeros-Rojas, O., Gálvez-Romero, J. L., Bellanti, J. A., & Torres, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.987231 · Cited by 11
Candida auris: An emerging fungus that presents a serious global health threat.
Shariq, A., Rasheed, Z., Alghsham, R. S., & Abdulmonem, W. A. (2023) · PubMed Central · Cited by 13
Bioinspired peptides induce different cell death mechanisms against opportunistic yeasts
Lucas, D. R., Damica, F. Z., Toledo, E. B., Cogo, A. J. D., Okorokova‐Façanha, A. L., Gomes, V. M., & Carvalho, A. D. O. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10064-8 · Cited by 10
“Most worryingly, out of the 54 isolates, 41% were resistant to two classes of antifungals, and 4% were resistant to three classes [17].”
Invasive fungal infections in hemato-oncology
Oberoi, J. K., Sheoran, L., Sagar, T., & Saxena, S. (2023) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2023.01.011 · Cited by 10
Biswas, B., Rana, A., Gupta, N., Gupta, I., Puria, R., & Thakur, A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00892-23 · Cited by 10
Enablers of Candida auris persistence on medical devices and their mode of eradication.
Nwachukwu, K. C., Nwarunma, E., Uchenna, C. D., & Ugbogu, O. C. (2023) · PubMed Central · doi:10.18502/cmm.2023.150673 · Cited by 15
“In a genomic study performed by Lockhart and colleagues[15], over 7 chromosomes were identified; with an estimated 5,500 genes between 12.1 to 12.7 Mb [16].”
BackgroundInfluentialAreitio, M., Antoran, A., Rodriguez-Erenaga, O., Aparicio-Fernandez, L., Martin–Souto, L., Buldain, I., Zaldibar, B., Gaitán, A. C. R., Pemán, J., Rementería, A., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00752 · Cited by 10
Casimiro-Ramos, A., Bautista-Crescencio, C., Vidal-Montiel, A., González, G. M., Hernández-García, J. A., Hernández-Rodríguez, C., & Villa‐Tanaca, L. (2024) · Journal of Fungi · doi:10.3390/jof10060392 · Cited by 12
“Clade I is manifested in South Asia, II in East Asia, III in Africa, IV in South America, and V in Iran [4–6].”
BackgroundInfluentialCavallo, L., Menotti, F., Roana, J., Costa, C. S., Longo, F., Pagano, C., Curtoni, A., Bondi, A., Banche, G., Allizond, V., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070957 · Cited by 10
Doorley, L. A., Meza-Perez, V., Jones, S. J., & Rybak, J. M. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf285 · Cited by 14
“Candidozyma (Candida) auris is an emerging fungal pathogen recognized by the Centers for Disease Control and Prevention (CDC) as an increasing threat to public health, calling for “ur-gent and aggressive action” [1, 2].”
Jabeen, K., Khan, M., Umar, S., Shaheen, N., & Farooqi, J. Q. (2020) · Journal of Burn Care & Research · doi:10.1093/jbcr/iraa148 · Cited by 10
Self-citationBorman, A. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2417-3_23 · Cited by 10
Cell Viability Assays for Candida auris
Brown, J. L., Short, B., Ware, A., Sherry, L., Kean, R., & Ramage, G. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2417-3_10 · Cited by 11
Clorgyline Analogs Synergize with Azoles against Drug Efflux in Candida auris
Toepfer, S., Lackner, M., Keniya, M. V., Zenz, L.-M., Friemert, M., Bracher, F., & Monk, B. C. (2023) · Journal of Fungi · doi:10.3390/jof9060663 · Cited by 11
“Point mutations homologous to these in C. albicans have been found in specific associations with C. auris clades: CauErg11 Y132F is found in clades I, IV, and V; K143R in clades I and IV; and F126L substitution is found exclusively in clade III [3,19,23].”
BackgroundInfluentialCodon usage bias analysis of mitochondrial protein-coding genes in 12 species of Candida
Wang, F., Zhang, N., Zhao, C., Song, Z., & Xin, C. (2023) · Journal of Genetics · doi:10.1007/s12041-023-01434-w · Cited by 10
Emerging Pathogens of the Candida Species
Yang, B., & Rao, R. P. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80378 · Cited by 11
Fungal immunology in clinical practice: Magical realism or practical reality?
Chang, C. C., & Levitz, S. M. (2019) · Medical Mycology · doi:10.1093/mmy/myy165 · Cited by 10
Alastruey‐Izquierdo, A., Asensio, Á., Besolí, A., Calabuig, E., Fernández‐Ruiz, M., García‐Vidal, C., Gasch, O., Guinea, J., Martín-Gómez, M. T., Paño, J. R., et al. (2019) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2019.06.001 · Cited by 10
Nunnally, N. S., Damm, T., Lockhart, S. R., & Berkow, E. L. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.02355-20 · Cited by 11
“The infection is challenging to treat, as resistance to fluconazole is widespread and susceptibility to other azoles, amphotericin B and the echinocandins, is variable (4).”
BackgroundMethodSelf-citationWells, K. M., Ciftci, Y., Peddinti, B. S. T., Ghiladi, R. A., Vediyappan, G., Spontak, R. J., & Govind, R. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.08.088 · Cited by 9
Guan, Q., Alasmari, F. A., Li, C., Mfarrej, S., Mukahal, M., Arold, S. T., AlMutairi, T., & Pain, A. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03260-24 · Cited by 9
“Whole genome sequencing (WGS) analysis of 75 global C. auris clinical isolates suggests the independent emergence of five populations of C. auris in three conti nents: South Asia, East Asia, Middle East (Iran), South Africa, and South America (2, 24) designated as clades I–V. Recently, an new clade of C auris , clade…”
InfluentialPerformance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida auris DNA
Buil, J. B., van den Bosch, B., van der Maas, S. J., Meijer, E. F. J., de Groot, T., Meletiadis, J., Verweij, P. E., Melchers, W. J. G., & Pas, S. D. (2025) · Mycoses · doi:10.1111/myc.70065 · Cited by 10
Chen, Y., Dhillon, S., Adomakoh, N., & Roberts, J. A. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2539427 · Cited by 9
Oh, D., Astashyn, A., Robbertse, B., O’Leary, N. A., Anderson, W. R., Breen, L., Cox, E. D., Ermolaeva, O. D., Falk, R., Hem, V., et al. (2025) · Journal of Molecular Evolution · doi:10.1007/s00239-025-10268-2 · Cited by 12
Singh, S., Youssef, E. G., Barbarino, A. M., Hautau, H., Nabeela, S., Gebremariam, T., Alkhazraji, S., Ostroff, G. R., Christensen, D., Cochrane, T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32488-8 · Cited by 10
Thermotolerance and Adaptation to Climate Change
Almaguer, M. (2022) · Fungal biology · doi:10.1007/978-3-030-89664-5_3 · Cited by 11
Carvajal, S. K., Melendres, J., Escandón, P., & Firacative, C. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01403-23 · Cited by 9
Candida auris: un agente patógeno global que se ha arraigado en Colombia
Escandón, P., Lockhart, S. R., Chow, N. A., & Chiller, T. M. (2023) · Biomédica · doi:10.7705/biomedica.7082 · Cited by 11
Self-citationKerai, A., Doshi, S., Laleker, A., & Majumdar, A. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae286 · Cited by 9
“However, 90% of C auris isolates in the USA are fluconazole-resistant [14].”
BackgroundGupta, N., Haughton, S., Kemper, S., Koehler, M., Antoon, R., Edwards, C. G., & Bardin-Spencer, A. J. (2024) · American Journal of Infection Control · doi:10.1016/j.ajic.2024.06.015 · Cited by 10
Screening a 681-membered yeast collection for the secretion of proteins with antifungal activity
Valero, A. M., Tabatabaeifar, F., & Billerbeck, S. (2025) · New Biotechnology · doi:10.1016/j.nbt.2025.01.008 · Cited by 9
Containment strategies to address the expanding threat of multidrug-resistant Candida auris
McCarthy, M. W., & Walsh, T. J. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1402678 · Cited by 9
“auris undergo antifungal susceptibility testing [49].”
Chesnay, A., Bailly, É., & Désoubeaux, G. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101173 · Cited by 11
Molecular investigation of the incidence of Candida auris infections at selected hospitals in Iran
Safari, F., Madani, M., Kheirollahi, M., & Mirhendi, H. (2022) · Mycoses · doi:10.1111/myc.13504 · Cited by 12
Jabeen, K., Mal, P. B., Tharwani, A., Hashmi, M., & Farooqi, J. Q. (2019) · Medical Mycology · doi:10.1093/mmy/myz033 · Cited by 9
Self-citationSullivan, K. E., Bassiri, H., Bousfiha, A. A., Costa‐Carvalho, B. T., Freeman, A. F., Hagin, D., Lau, Y., Lionakis, M. S., Moreira, I., Pinto, J. A., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0426-2 · Cited by 11
“auris have intrinsic resistance to fluconazole and other triazole antifungal agents, while a significant proportion of strains has elevated minimum inhibitory concentrations to amphotericin B and echinocandins, with some strains reportedly resistant to all three classes of azoles, polyenes, and echinocandins [64].”
BackgroundAzole Antifungal Drugs: Mode of Action and Resistance
Garcia‐Rubio, R., Monteiro, M. C., & Mellado, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20731-0 · Cited by 9
Candida auris metabolism and growth preferences in physiologically relevant skin-like conditions
Nicklas, J. P., Deming, C., Lee-Lin, S., Conlan, S., Shen, Z., Blaustein, R. A., & Segre, J. A. (2026) · mBio · doi:10.1128/mbio.03117-25 · Cited by 8
Impact of Micafungin on Candida auris β-glucan Masking and Neutrophil Interactions
Horton, M. V., Eix, E. F., Johnson, C. J., Dean, M. E. B., Andes, B. D., Wartman, K. M., & Nett, J. E. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae043 · Cited by 8
Smithgall, M. C., Kılıç, A., Weidmann, M. D., Ofori, K., Gu, Y., Koganti, L., Mi, S., Xia, H., Shi, J., Pang, J., et al. (2025) · Clinical Chemistry · doi:10.1093/clinchem/hvae185 · Cited by 9
Tsai, D. H., Wu, I. C.-Y., Chang, L.-F., Lu, M. J.-H., Debnath, B., Govender, N. P., Sharland, M., Warris, A., Hsia, Y., & Ferreras-Antolin, L. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf329 · Cited by 10
Self-citationDring, J. C., Kaczynski, M., Zureikat, R. M., Kaczynski, M., Forma, A., & Baj, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146821 · Cited by 12
“These isolates were characterized by high levels of antifungal resistance, particularly to azoles such as fluconazole, due to mutations in key genes including ERG11 and TAC1B [83,116–119].”
Zhu, Q., de Velde, S. V., Wijnants, S., Carolus, H., Jacobs, S., Sofras, D., Vandecruys, P., Goethem, O. V., Feil, R., Vergauwen, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67022-x · Cited by 10
“The parental strains used in this study weresingle colony isolates from clinicalstrainsof Pakistan (Clade I) 8 ,SouthAfrica(CladeIII) 8 , Colombia (Clade IV) 72 and Iran (Clade V) 73 .”
Gifford, H., Bedekovic, T., Helmstetter, N., Gregory, J., Ma, Q., Brand, A., Wilson, D., Rhodes, J. L., Ramsdale, M., Kudoh, T., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-09321-z · Cited by 11
Zhang, S. X., de Hoog, S., Denning, D. W., Ahmed, S. A., Alastruey‐Izquierdo, A., Arendrup, M. C., Borman, A. M., Chen, S., Chowdhary, A., Colgrove, R. C., et al. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.01550-25 · Cited by 16
Self-citationDeciphering the multidrug resistance paradigm in Candida auris
Santana, D. J., Cauldron, N. C., Rogers, P. D., & Cuomo, C. A. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01062-24 · Cited by 10
Self-citationUpdated Genomic Epidemiologic Description of Candida (Candidozyma) auris , United States
Parnell, L. A., dos Santos, A. R., Forsberg, K., Lyman, M., Misas, E., Gade, L., Sexton, D. J., Litvintseva, A. P., & Chow, N. A. (2026) · Emerging infectious diseases · doi:10.3201/eid3205.250760 · Cited by 10
Self-citationMrs4 loss of function in fungi during adaptation to the cystic fibrosis lung
Murante, D., Demers, E. G., Kurbessoian, T., Ruzic, M., Ashare, A., Stajich, J., & Hogan, D. A. (2023) · mBio · doi:10.1128/mbio.01171-23 · Cited by 9
“271 First, we assessed the activity of Mrs4 variants in Candida auris, a fungus that emerged within the past 272 forty years (29) and is closely related to C.”
Bohner, F., Papp, C., Takács, T., Varga, M., Szekeres, A., Nosanchuk, J. D., Vágvölgyi, C., Tóth, R., & Gácser, A. (2023) · Journal of Fungi · doi:10.3390/jof9121148 · Cited by 10
“These groups were originally associated with specific geographical locations: Clade I with South Asia, Clade II with East Asia, Clade III with Africa, Clade IV with South America, and Clade V with Iran [8–10].”
BackgroundVertebrate and invertebrate animal infection models of Candida auris pathogenicity
Martinez, M., Garsin, D. A., & Lorenz, M. C. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102506 · Cited by 8
Yang, J.-X., Ma, G., Li, Y.-T., Shi, Y.-P., & Liang, G.-W. (2024) · Clinics · doi:10.1016/j.clinsp.2024.100497 · Cited by 9
Magrì, C., Carolis, E. D., Ivagnes, V., Pilato, V. D., Spruijtenburg, B., Marchese, A. E., Meijer, E. F. J., Chowdhary, A., & Sanguinetti, M. (2024) · Microorganisms · doi:10.3390/microorganisms12112153 · Cited by 9
Self-citationShould all hospitalised patients colonised with Candida auris be considered for isolation?
Meijer, E. F. J., & Voß, A. (2024) · Eurosurveillance · doi:10.2807/1560-7917.es.2024.29.45.2400729 · Cited by 9
“Candida auris has demonstrated a notable propensity for rapid resistance development and is the first Candida species to have acquired pan-drug resistance [11].”
Background
Metadata
- Authors
- Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., Berkow, E. L., Castanheira, M., Magobo, R. E., Jabeen, K., Asghar, R. J., Meis, J. F., Jackson, B., Chiller, T., & Litvintseva, A. P.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Aga Khan University (PK)
- University of Delhi (IN)
- National Health Laboratory Service (ZA)
- Universidade Federal de São Paulo (BR)
- Universidad del Zulia (VE)
- Broad Institute (US)
- JMI Laboratories (US)
- Radboud University Nijmegen (NL)
- ORCID
- Lockhart, Shawn R.
- Vallabhaneni, Snigdha
- Farooqi, Joveria
- Chowdhary, Anuradha
- Govender, Nelesh P.
- Colombo, Arnaldo Lopes
- Cuomo, Christina A.
- Desjardins, Christopher A.
- Berkow, Elizabeth L.
- Castanheira, Mariana
- Magobo, Rindidzani E.
- Jabeen, Kauser
- Asghar, Rana J.
- Meis, Jacques F.
- Jackson, Brendan
- Chiller, Tom
- Litvintseva, Anastasia P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-20
- Volume
- 64
- Issue
- 2
- Pages
- 134-140
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5215215
- OpenAlex
- W2536287248
- Semantic Scholar
- c8d8e54651d8fb7a7ece68270cd2630d1cd0df39
- Cited by
- 1,662
- References
- 32
- Citations by year
- 2026: 196 · 2025: 194 · 2024: 203 · 2023: 186 · 2022: 160 · 2021: 178 · 2020: 187 · 2019: 152 · 2018: 116 · 2017: 81 · 2016: 5
- FWCI
- 108.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- public-domain
- Locations
- Clinical Infectious Diseases (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U19AI110818)
- United States Agency for International Development (4-338/PAK-US/HEC/2010/932)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida auris, multidrug resistance, antifungal resistance, clonal populations, ERG11 mutations, azole resistance, fluconazole resistance, bloodstream infection, invasive candidiasis, nosocomial infections, risk factors, transmission, whole genome sequencing, antifungal susceptibility
- MeSH terms
- Whole Genome Sequencing, Adolescent, Adult, Aged, Antifungal Agents, Candida, Candidiasis, Child, Child, Preschool, Cytochrome P-450 Enzyme System, Female, Humans, Infant, Infant, Newborn, Male, Microbial Sensitivity Tests, Middle Aged, Mutation, Phylogeny, RNA, Ribosomal, 28S, Global Health, Genome, Fungal, Drug Resistance, Multiple, Polymorphism, Single Nucleotide, DNA, Ribosomal Spacer, Drug Resistance, Fungal, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.